Target intelligence / Profile preview

Membrane protein BRI3 (BRI3)

Target
BRI3
Molecular classification
Other (membrane protein, not classified as receptor, ion channel, enzyme, transporter, or transcription factor)
01

Overview

Membrane protein BRI3 (BRI3) is a highly conserved, proline-rich transmembrane protein that contains three pairs of cysteine residues within a 42-amino-acid region[4][5]. Its expression is upregulated by Wnt/β-catenin signaling and is thought to play a role in the regulation of cell fate, especially through participation in tumor necrosis factor-alpha (TNF)-induced cell death pathways[1][2][8]. BRI3 has been identified in plasma membrane and azurophil granule membranes and has identical protein binding activity. Experimental evidence links BRI3 to pathways involved in apoptosis and suggests it may modulate both developmental and disease-related cellular processes by integrating Wnt/β-catenin transcriptional responses with apoptotic signaling[1][2][8]. There is limited but emerging evidence of BRI3 involvement in neurodegenerative conditions and cancer; however, it is not currently established as a therapeutic drug target or biomarker[1][2].

Other names
Brain protein I3I3pRGR2BRI3_HUMANI3 protein
02

Biological functions

Cell death (specifically tumor necrosis factor-alpha (TNF)-induced cell death)Likely involved in apoptosisRegulation of cell fateParticipation in Wnt/β-catenin signaling pathwayProtein binding activity
03

Disease associations

Neurodegenerative disease (regulation of amyloid precursor protein processing, as suggested from NCBI Gene)Cancer (involvement in cell proliferation and death pathways, some associations with cancer datasets)Other (diseases such as developmental and epileptic encephalopathy are mentioned in GeneCards, but with limited direct mechanistic connection)

Beyond the preview

Go deeper on Membrane protein BRI3 (BRI3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane protein BRI3 (BRI3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call